MENU
+Compare
IMA
Stock ticker: NASDAQ
AS OF
Sep 26, 04:28 PM (EDT)
Price
$7.75
Change
-$0.03 (-0.39%)
Capitalization
86.99M

IMA ImageneBio Inc Forecast, Technical & Fundamental Analysis

ImageneBio Inc is a clinical-stage biopharmaceutical company that develops differentiated therapies for immunological and inflammatory (I&I) diseases... Show more

IMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for IMA with price predictions
Sep 25, 2025

IMA's RSI Oscillator is staying in oversold zone for 7 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

IMA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 22, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on IMA as a result. In of 101 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

IMA moved below its 50-day moving average on September 09, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for IMA crossed bearishly below the 50-day moving average on September 16, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 9 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IMA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for IMA entered a downward trend on September 25, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (19.661). P/E Ratio (0.000) is within average values for comparable stocks, (53.961). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.097). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (24.876) is also within normal values, averaging (344.769).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. IMA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IMA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
IMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

IMA is expected to report earnings to rise 4.35% to -72 cents per share on November 06

ImageneBio Inc IMA Stock Earnings Reports
Q3'25
Est.
$-0.72
Q2'25
Missed
by $0.55
The last earnings report on July 24 showed earnings per share of -68 cents, missing the estimate of -14 cents. With 1.70K shares outstanding, the current market capitalization sits at 86.99M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SVVC0.06N/A
+2.77%
Firsthand Technology Value Fund, Inc.
SVMLF0.470.01
+1.20%
Sovereign Metals Ltd.
ASEKY17.22N/A
N/A
Aisin Corporation
LLEIF1.45N/A
N/A
Lleidanetworks Serveis Telematics S A
FRLOF0.75N/A
N/A
FRASERS LOGISTICS & Commercial Trust

IMA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, IMA has been closely correlated with CELC. These tickers have moved in lockstep 84% of the time. This A.I.-generated data suggests there is a high statistical probability that if IMA jumps, then CELC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMA
1D Price
Change %
IMA100%
-2.75%
CELC - IMA
84%
Closely correlated
-3.78%
INCY - IMA
28%
Poorly correlated
-2.97%
TRML - IMA
24%
Poorly correlated
-0.06%
MNOV - IMA
23%
Poorly correlated
-0.80%
ALXO - IMA
20%
Poorly correlated
+15.48%
More

Groups containing IMA

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMA
1D Price
Change %
IMA100%
-2.75%
IMA
(2 stocks)
92%
Closely correlated
-1.48%